pneumonia
Showing 9976 - 10000 of >10,000
Maraviroc In Patients For HIV Patients
Completed
- CCR5-tropic HIV-1 Infection
- CELSENTRI® Tablets
- (no location specified)
Dec 6, 2019
Infections, Papillomavirus, Papillomavirus Vaccines Trial in United States (GSK Biologicals HPV 16/18 vaccine 580299
Completed
- Infections, Papillomavirus
- Papillomavirus Vaccines
- GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)
- +2 more
-
Chandler, Arizona
- +39 more
Dec 27, 2019
Staphylococcal Skin Infection Trial in New Orleans (Telavancin, Vancomycin)
Completed
- Staphylococcal Skin Infection
-
New Orleans, LouisianaLouisiana State University Health Sciences Center, Dept of Med/E
Jan 14, 2019
Birth Cohort Study for Respiratory Infections
Completed
- Upper Respiratory Tract Infections
-
Dhaka, BangladeshInternational Center for Diarrheal Disease Research
Apr 5, 2018
Erlotinib Plus Gemcitabine in Metastatic Pancreatic Cancer
Completed
- Pancreatic Cancer
-
Köln, GermanyKlinikum der Universität zu Köln Klinik für Gastroenterologie am
Oct 12, 2017
Trauma Trial in Canada, United States (1:1:1 Blood Transfusion Ratio, 1:1:2 Blood Transfusion Ratio)
Completed
- Trauma
- 1:1:1 Blood Transfusion Ratio
- 1:1:2 Blood Transfusion Ratio
-
Birmingham, Alabama
- +11 more
Feb 6, 2019
Prostate Cancer Trial in Park Ridge (Tarceva)
Completed
- Prostate Cancer
-
Park Ridge, IllinoisOncology Specialists, SC
May 31, 2018
Rituximab (MabThera) in Chronic Lymphocytic Leukemia (CLL)
Completed
- Lymphocytic Leukemia, Chronic
-
Frechen, GermanyPIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
Dec 8, 2017
Seizures Trial in United States (Cannabidiol Oral Solution)
Completed
- Seizures
- Cannabidiol Oral Solution
-
San Francisco, California
- +10 more
Jun 26, 2018
Evaluation of Pneumococcal Vaccine Coverage
Completed
- Immunocompromised Patients and Non-immunosuppressed Patients at Risk With an Indication for Pneumococcal Vaccination
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Feb 12, 2019
End Stage Renal Disease Trial in Puerto Rico, United States (Soluble Ferric Pyrophosphate in liquid bicarbonate, Placebo:
Completed
- End Stage Renal Disease
- Soluble Ferric Pyrophosphate in liquid bicarbonate
- +3 more
-
Birmingham, Alabama
- +22 more
Aug 27, 2018
Mantle Cell Lymphoma Trial in Worldwide (Rituximab 375 mg/m^2, Cyclophosphamide 750 mg/m^2, Doxorubicin 50 mg/m^2)
Completed
- Mantle Cell Lymphoma
- Rituximab 375 mg/m^2
- +5 more
-
Hartford, Connecticut
- +149 more
Jun 14, 2018
Venous Thromboembolism (VTE) Trial in Worldwide (Betrixaban, Enoxaparin)
Completed
- Venous Thromboembolism (VTE)
-
Birmingham, Alabama
- +462 more
Sep 24, 2018
Complicated Intra Abdominal Infections Trial in Canada, United States (ampicillin and metronidazole and gentamicin, ampicillin
Completed
- Complicated Intra Abdominal Infections
- ampicillin and metronidazole and gentamicin
- +4 more
-
Birmingham, Alabama
- +49 more
May 28, 2019
Tuberous Sclerosis Complex-associated Refractory Seizures Trial in Worldwide (RAD001, Placebo, Antiepileptic drug (1 to 3 only))
Completed
- Tuberous Sclerosis Complex-associated Refractory Seizures
- RAD001
- +3 more
-
Birmingham, Alabama
- +103 more
Nov 6, 2018
Atrial Fibrillation Trial in United States (Arctic Front Cardiac Cryoablation System)
Completed
- Atrial Fibrillation
- Arctic Front Cardiac Cryoablation System
-
Phoenix, Arizona
- +9 more
Sep 17, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Anniston, Alabama
- +145 more
May 28, 2019
New-onset Atrial Fibrillation in Critically Ill Sepsis Patients
Completed
- Atrial Fibrillation New Onset
- Red Cell Distribution Width
- (no location specified)
May 2, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Concord, California
- +96 more
Mar 6, 2019
Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody, Bevacizumab, Sunitinib)
Completed
- Renal Cell Carcinoma
- Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
- +2 more
-
Scottsdale, Arizona
- +44 more
Dec 19, 2019